September 27, 2012

Treatment Options for Liver Cancer


Options (options) treatment is dictated by the circumstances of liver cancer and the patient's overall condition. The only cure for liver cancer has been proven is a liver transplant for a small tumor (less than 3 cm) of a separate (remote).
Now, many doctors may argue with this statement. They may argue that a small tumor can be removed surgically (penyayatan liver in part) without the need for a transplant (transplant) heart. More than that, they may declare happy survival numbers one and three years for penyayatan is probably comparable to those for liver transplantation.
However, most patients with liver cancer also have cirrhosis of the liver and will not tolerate incision heart surgery. However, they may be able to tolerate transplant surgery, which involves removing all the diseased hearts of patients just before transplantation of a liver donor. Furthermore, many patients who undergo liver incisions will develop a recurrence of liver cancer elsewhere in the liver within a few years. In fact, some experts believe that once the liver develop liver cancer, there is a tendency to develop liver tumors was another at the same time (synchronous multicentric occurrence) or at a later time (metachronous multicentric occurrence).
The results of medical treatments are diverse (chemotherapy, kemoembolisasi, ablation, and proton beam therapy) remain disappointing. More than that, for reasons noted earlier (in particular the diversity in the natural history), has been no study that systematic comparisons of different treatments. As a result, individual patients will find that the treatment options available to them vary depending largely on local expertise.
How do we know if a particular treatment worked for a particular patient? Well, hopefully, the patient will feel better. However, a clinical response to treatment is usually defined more objectively. Thus, a response is defined as a reduction in tumor size on imaging studies along with a reduction (reduction) of alpha-fetoprotein in the blood, if the rate rises before the treatment.
Posted by at
Labels:

Treatment Options for Liver Cancer


Options (options) treatment is dictated by the circumstances of liver cancer and the patient's overall condition. The only cure for liver cancer has been proven is a liver transplant for a small tumor (less than 3 cm) of a separate (remote).
Now, many doctors may argue with this statement. They may argue that a small tumor can be removed surgically (penyayatan liver in part) without the need for a transplant (transplant) heart. More than that, they may declare happy survival numbers one and three years for penyayatan is probably comparable to those for liver transplantation.
However, most patients with liver cancer also have cirrhosis of the liver and will not tolerate incision heart surgery. However, they may be able to tolerate transplant surgery, which involves removing all the diseased hearts of patients just before transplantation of a liver donor. Furthermore, many patients who undergo liver incisions will develop a recurrence of liver cancer elsewhere in the liver within a few years. In fact, some experts believe that once the liver develop liver cancer, there is a tendency to develop liver tumors was another at the same time (synchronous multicentric occurrence) or at a later time (metachronous multicentric occurrence).
The results of medical treatments are diverse (chemotherapy, kemoembolisasi, ablation, and proton beam therapy) remain disappointing. More than that, for reasons noted earlier (in particular the diversity in the natural history), has been no study that systematic comparisons of different treatments. As a result, individual patients will find that the treatment options available to them vary depending largely on local expertise.
How do we know if a particular treatment worked for a particular patient? Well, hopefully, the patient will feel better. However, a clinical response to treatment is usually defined more objectively. Thus, a response is defined as a reduction in tumor size on imaging studies along with a reduction (reduction) of alpha-fetoprotein in the blood, if the rate rises before the treatment.